Abstract
The use of agents capable of impairing RTK function is gaining prominence for their effectiveness against the tumorigenic program driven by oncogenic RTK activity in a wide range of cancer cells. Having this valuable resource in hand for molecularly targeted anticancer therapies, it is mandatory to understand how to use these agents properly for combined treatments in order to maximize clinical efficacy. The remarkable plasticity and adaptation of cancer cells should also be taken into account, since this leads to the acquisition of “resistance” during treatment. By revisiting mechanisms of drug resistance found in cancer cells and by intercalating new emerging concepts on RTK signaling coming from cancer genome studies, this review discusses strategies aimed to enhance the effectiveness of RTK blocking agents and overcome resistance to treatment.
Keywords: RTK-addiction, oncogenic RTKs, RTK anticancer agents, mechanism of drug action, resistance mechanisms, cell plasticity.
Current Medicinal Chemistry
Title:Strategies to Overcome Drug Resistance of Receptor Tyrosine Kinaseaddicted Cancer Cells
Volume: 21 Issue: 14
Author(s): Flavio Maina
Affiliation:
Keywords: RTK-addiction, oncogenic RTKs, RTK anticancer agents, mechanism of drug action, resistance mechanisms, cell plasticity.
Abstract: The use of agents capable of impairing RTK function is gaining prominence for their effectiveness against the tumorigenic program driven by oncogenic RTK activity in a wide range of cancer cells. Having this valuable resource in hand for molecularly targeted anticancer therapies, it is mandatory to understand how to use these agents properly for combined treatments in order to maximize clinical efficacy. The remarkable plasticity and adaptation of cancer cells should also be taken into account, since this leads to the acquisition of “resistance” during treatment. By revisiting mechanisms of drug resistance found in cancer cells and by intercalating new emerging concepts on RTK signaling coming from cancer genome studies, this review discusses strategies aimed to enhance the effectiveness of RTK blocking agents and overcome resistance to treatment.
Export Options
About this article
Cite this article as:
Maina Flavio, Strategies to Overcome Drug Resistance of Receptor Tyrosine Kinaseaddicted Cancer Cells, Current Medicinal Chemistry 2014; 21 (14) . https://dx.doi.org/10.2174/09298673113209990222
DOI https://dx.doi.org/10.2174/09298673113209990222 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Development of Nucleic Acid Drugs for Neurological Disorders
Current Topics in Medicinal Chemistry Vitamin D and Metabolic Syndrome: Is There a Link?
Current Pharmaceutical Design MMP-9 Inhibitors in the Brain: Can Old Bullets Shoot New Targets?
Current Pharmaceutical Design Cellular Antiviral Factors that Target Particle Infectivity of HIV-1
Current HIV Research A Review on Molecular Mechanisms and Patents of Marine-derived Anti-thrombotic Agents
Current Drug Targets ATP Non-Competitive Ser/Thr Kinase Inhibitors as Potential Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Targeting the L-Arginine-Nitric Oxide Pathway for Cancer Treatment
Current Pharmaceutical Design Low Molecular Weight and Oligomeric Chitosans and Their Bioactivities
Current Topics in Medicinal Chemistry Cellular and Molecular Mechanisms of Lymphangiogenesis and Lymphedema
Current Cancer Therapy Reviews Therapeutic Approaches to Modulating Glutathione Levels as a Pharmacological Strategy in Alzheimer`s Disease
Current Alzheimer Research TRP Channels: Emerging Links Between Ca2+, Kidney and Hypertension
Current Hypertension Reviews Mammary Development and Breast Cancer: The Role of Stem Cells
Current Molecular Medicine Genetic and Modifying Factors that Determine the Risk of Brain Tumors
Central Nervous System Agents in Medicinal Chemistry “Self-Antigenic Universe” and Tuberculosis Vaccine Development
Current Pharmacogenomics and Personalized Medicine Targeting EZH2 for Cancer Therapy: Progress and Perspective
Current Protein & Peptide Science MicroRNAs in Lung Cancer and Lung Cancer Bone Metastases: Biomarkers for Early Diagnosis and Targets for Treatment
Recent Patents on Anti-Cancer Drug Discovery Methods to Access 2-aminobenzimidazoles of Medicinal Importance
Current Organic Chemistry The Role of ING Tumor Suppressors in UV Stress Response and Melanoma Progression
Current Drug Targets A Review of Mechanisms of Circumvention and Modulation of Chemotherapeutic Drug Resistance
Current Cancer Drug Targets CYP17 Inhibitors for Prostate Cancer Treatment – An Update
Current Medicinal Chemistry